Newsletter | April 6, 2021

04.06.21 -- How To Accelerate Your Biopharmaceutical Development Into The Digital Age

 
Fast And Effective Digital Transformation
 

Most biopharmaceutical executives have experience with lengthy software customization projects that have delivered underwhelming results. Taking an out-of-the-box approach and delivering workflows which reflect industry best practices can significantly accelerate project timelines, reduce risk, and enable biopharmaceutical companies to realize the benefits and business value much sooner.

Why Biopharma Lifecycle Management?
 

Biopharma 4.0 is a bold vision, with smart factories and process automation driven by real-time data to constantly ensure quality and efficiency. The biopharma industry has big ambitions to accelerate the move toward industry 4.0. This article explores some of the major bottlenecks in the development life cycle and the current barriers to effective digital transformation.

What’s Delaying The Move Toward Biopharma 4.0?
 

We have patiently listened to the grand vision of smart processes that continuously learn from data, optimize conditions, and predict the future, all in a couple of seconds. The promise is of a coming enterprisewide network that promotes communication and strategic insight, while controlling manufacturing, logistics, and supply chains, for shorter time-to-market at lower cost. So, what's the hold up?

Achieving A F.A.I.R. Data Management Strategy
 

Recently, many industry leaders have been highlighting the problems of not having F.A.I.R. data. For example, a recent report estimates that data that is not findable, understandable, or has incomplete metadata introduces inefficiencies and negatively impacts research quality, ultimately costing the European economy in excess of €26 billion per year. Learn what the F.A.I.R. principles mean in practical terms for your R&D data management strategy.